Fluidx Medical Reports Initial Research on First-of-its-Kind Embolic Agent with Intermediate Radiopacity
Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors
Novel Oncology Embolic Device financing supports prospective, clinical trials and market entry
Fluidx Medical’s GPX Embolic Device Releases Initial Results for Oncology Drug Delivery
Fluidx Medical’s GPX™ Embolic Device Use for Tumor Treatments Chosen for “BEST of GEST” Embolization Program at the Annual GEST Meeting.